Home - Products - Angiogenesis - PDE - 5,7-Diacetoxy-8-methoxyflavone

5,7-Diacetoxy-8-methoxyflavone

CAS No. 23246-80-2

5,7-Diacetoxy-8-methoxyflavone( ZINC77031696 )

Catalog No. M29268 CAS No. 23246-80-2

5,7-Diacetoxy-8-methoxyflavone is derived from the roots of Scutellaria baicalensis and inhibits cAMP phosphodiesterase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 257 In Stock
10MG 372 In Stock
25MG 599 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    5,7-Diacetoxy-8-methoxyflavone
  • Note
    Research use only, not for human use.
  • Brief Description
    5,7-Diacetoxy-8-methoxyflavone is derived from the roots of Scutellaria baicalensis and inhibits cAMP phosphodiesterase.
  • Description
    5,7-Diacetoxy-8-methoxyflavone is derived from the roots of Scutellaria baicalensis and inhibits cAMP phosphodiesterase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ZINC77031696
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23246-80-2
  • Formula Weight
    368.34
  • Molecular Formula
    C20H16O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OC=1C=C(OC(=O)C)C=2C(=O)C=C(OC2C1OC)C=3C=CC=CC3)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Verofylline

    Verofylline (Verofyllinum) is an orally available, long-acting, multiacting, methylxanthine-substituted bronchodilator with inhibitory effects on PDE4 for the treatment of asthma disease research obesity.

  • D 159687

    D159687 is a selective?PDE4D?inhibitorhad a procognitive profile as it improved memory in the novel object recognition test but had no antidepressant or anxiolytic benefit.

  • PDE10-IN-1

    PDE10-IN-1 is PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1 for treating CNS and metabolic disorders.